Averion International Corp. (Averion) is a global full-service clinical research organization with proven expertise in designing, performing and managing drug, biologic and medical device trials. Our clinical services support the full product development lifecycle, from first-in-man through regulatory approval and beyond. Averion has a powerful focus in the areas of Oncology, Cardiovascular Diseases and Medical Devices. The company operates in North America, South America, Europe, and the Asia/Pacific region.
Averion’s core competencies are in agency product registration support, site selection, project management, medical and site monitoring, data management, biometrics, pharmacovigilance, medical writing, and full clinical trial management services throughout the clinical trials lifecycle. The Company has supported approvals for products in many therapeutic areas including: oncology, cardiovascular diseases and medical devices.
Averion is committed to providing clients with critical thinking, customer service and quality deliverables. Our 25 years of experience allows us to optimize each investigational product's chance for success.
We are dedicated to ensuring that each clinical trial is executed to the highest possible standards. For companies worldwide, Averion is a trusted partner in clinical research.